Clinical Trial Update: cePolyTregs in Islet Transplantation [Phase 1]

View source ↗

Summary

A Phase 1 trial of cePolyTregs for islet transplantation in type 1 diabetes has been withdrawn. Sponsor is the University of Alberta.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• cePolyTregs

Snippet

Sponsor: University of Alberta | Conditions: Diabetes type1 | Phase 1 | Status: WITHDRAWN